Accelerating life-changing breakthroughs to cure, prevent and treat T1D and its complications
JDRF is the only global organization with a strategic research plan to end type 1 diabetes (T1D). Our plan ensures that there will be an ongoing stream of life-changing therapies moving from development through to commercialization that lessen the impact of T1D. We want to keep people with T1D healthy and safe today until we reach our ultimate goal of a cure and universal prevention of T1D.
JDRF collaborates with a wide spectrum of partners at every stage of the drug delivery pipeline and is the only organization with the scientific resources, regulatory influence, and a strategic plan to deliver a world without T1D. JDRF’s influence and leadership extends beyond funding research. We strategically partner with industry, governments, foundations, academia and clinicians, because curing T1D is a global, coordinated effort with JDRF at the center.
For more information, please visit www.jdrf.org.
JDRF leads the global Type 1 Diabetes support and research effort to keep people healthy and safe until we find a cure for the disease. Help create a world without T1D.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Other 5 Feb 2024 | | |
Nasdaq Finance, Financial Services | Nasdaq Finance, Financial Services | Other 21 May 2019 | | |
Catapult.org National and local authorities, Civic & Social Organization | Catapult.org National and local authorities, Civic & Social Organization | Other 10 Apr 2020 | | |
Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 7 Oct 2022 | |